Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions for surgical fixation of bone fractures for upper and lower extremities, as well as for the craniomaxillofacial region.
Excellent balance sheet with reasonable growth potential.
Share Price & News
How has Medartis Holding's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: MED has not had significant price volatility in the past 3 months.
7 Day Return
CH Medical Equipment
1 Year Return
CH Medical Equipment
Return vs Industry: MED underperformed the Swiss Medical Equipment industry which returned 1.1% over the past year.
Return vs Market: MED underperformed the Swiss Market which returned 3.8% over the past year.
Price Volatility Vs. Market
How volatile is Medartis Holding's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 days ago | Simply Wall StIs Medartis Holding AG (VTX:MED) Investing Your Capital Efficiently?
4 weeks ago | Simply Wall StCould The Medartis Holding AG (VTX:MED) Ownership Structure Tell Us Something Useful?
1 month ago | Simply Wall StShould You Use Medartis Holding's (VTX:MED) Statutory Earnings To Analyse It?
Is Medartis Holding undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate MED's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate MED's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: MED is poor value based on its PE Ratio (229.7x) compared to the Medical Equipment industry average (41.7x).
PE vs Market: MED is poor value based on its PE Ratio (229.7x) compared to the Swiss market (19.8x).
Price to Earnings Growth Ratio
PEG Ratio: MED is poor value based on its PEG Ratio (6.6x)
Price to Book Ratio
PB vs Industry: MED is good value based on its PB Ratio (2.3x) compared to the CH Medical Equipment industry average (5.4x).
How is Medartis Holding forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MED's forecast earnings growth (35% per year) is above the savings rate (-0.2%).
Earnings vs Market: MED's earnings (35% per year) are forecast to grow faster than the Swiss market (8.7% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: MED's revenue (8% per year) is forecast to grow faster than the Swiss market (2.4% per year).
High Growth Revenue: MED's revenue (8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MED's Return on Equity is forecast to be low in 3 years time (0.9%).
How has Medartis Holding performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MED has high quality earnings.
Growing Profit Margin: MED's current net profit margins (1.6%) are lower than last year (3.5%).
Past Earnings Growth Analysis
Earnings Trend: MED's earnings have declined by -22% per year over the past 5 years.
Accelerating Growth: MED's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: MED had negative earnings growth (-48.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (-13.5%).
Return on Equity
High ROE: MED's Return on Equity (1%) is considered low.
How is Medartis Holding's financial position?
Financial Position Analysis
Short Term Liabilities: MED's short term assets (CHF180.9M) exceed its short term liabilities (CHF30.1M).
Long Term Liabilities: MED's short term assets (CHF180.9M) exceed its long term liabilities (CHF42.8M).
Debt to Equity History and Analysis
Debt Level: MED's debt to equity ratio (0.01%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if MED's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: MED's debt is well covered by operating cash flow (26059.1%).
Interest Coverage: MED's interest payments on its debt are well covered by EBIT (11.5x coverage).
What is Medartis Holding's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate MED's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MED's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if MED's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MED's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of MED's dividend in 3 years as they are not forecast to pay a notable one for the Swiss market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Christoph Brönnimann (53yo)
Mr. Christoph Brönnimann has been Chief Executive Officer and Member of Executive Management Board of Medartis Holding AG since September 1, 2019 and has responsibility for the sales organisation since Nov ...
|CEO & Member of Executive Management Board||0.75yr||no data||0.013% CHF63.0k|
|CFO, Deputy CEO & Member of Executive Management Board||19.42yrs||no data||0.13% CHF618.6k|
|Chief Production Officer & Member of Executive Management Board||6yrs||no data||0.024% CHF117.6k|
|CTO & Member of Executive Management Board||7.67yrs||no data||0.032% CHF158.5k|
|Chief Human Resources Officer & Member of the Executive Management Board||1.42yrs||no data||no data|
|President of North America & Member of Executive Management Board||0.17yr||no data||no data|
|Head of Corporate Services||no data||no data||no data|
Experienced Management: MED's management team is considered experienced (3.7 years average tenure).
|Independent Director||0.17yr||no data||no data|
Experienced Board: MED's board of directors are considered experienced (6.9 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Medartis Holding AG's company bio, employee growth, exchange listings and data sources
- Name: Medartis Holding AG
- Ticker: MED
- Exchange: SWX
- Founded: 1997
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: CHF494.682m
- Shares outstanding: 11.78m
- Website: https://www.medartis.com
Number of Employees
- Medartis Holding AG
- Hochbergerstrasse 60E
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|MED||SWX (SIX Swiss Exchange)||Yes||Register Shares||CH||CHF||Mar 2018|
Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions for surgical fixation of bone fractures for upper and lower extremities, as well as for the craniomaxillofacial region. The company offers plates and screws solutions to treat various fractures, osteotomies, and degenerative diseases of hand, wrist, elbow, shoulder, and foot and ankle under the APTUS name; and implants for fracture fixations and osteotomies in the mandibular, and midface and cranial regions under the MODUS name. Medartis Holding AG’s products also used in tumor reconstruction and orthognathic deformities of the skull. The company sells its products through a network of direct sales representatives primarily to surgeons, hospitals, and medical centers, as well as to group purchasing organizations worldwide. Medartis Holding AG was founded in 1997 and is headquartered in Basel, Switzerland.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/06/04 10:24|
|End of Day Share Price||2020/06/03 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.